Free Newsletter
Seroquel user wants FDA to see sealed papers
A patient who claims the psychiatric drug Seroquel gave him diabetes has asked a judge to unseal AstraZeneca's confidential documents about its side effects--before the FDA decides whether to grant a new indication covering millions of patients with depression and/or anxiety. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: